Sector: Consumer Non-Cyclicals | Industry: Food Processing |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 521 W 57TH ST NEW YORK NY 10019 |
Tel: | 1-212-7087164 |
Website: | https://www.iff.com |
IR: | See website |
Key People | ||
J. Erik Fyrwald Chief Executive Officer, Director | Michael DeVeau Senior Vice President - Corporate Finance, Investor Relations | Glenn R. Richter Chief Financial and Business Transformation Officer, Executive Vice President |
Yuvraj Arora President, Nourish | Simon Herriott President - Health and Biosciences, President - Scent | Angela Strzelecki President, Pharma Solutions |
Deborah Borg Executive Vice President, Chief Human Resource Officer, Diversity and Inclusion Officer | Vic Verma Executive Vice President, Chief Information Officer | Jennifer Johnson Executive Vice President, General Counsel, Corporate Secretary | Ralf Finzel Executive Vice President, Global Operations Officer |
Business Overview |
International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage, health and biosciences, scent and pharma solutions and complementary adjacent products. The Company operates through four segments. Nourish segment consists of a portfolio of natural-based ingredients to enhance nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications and consists of ingredients, flavors and food designs. Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Scent segment creates fragrance compounds, fragrance ingredients and cosmetic ingredients. Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients. |
Financial Overview |
For the fiscal year ended 31 December 2023, International Flavors & Fragrances Inc revenues decreased 8% to $11.48B. Net loss applicable to common stockholders increased 37% to $2.57B. Revenues reflect Nourish segment decrease of 11% to $6.06B, Health & Biosciences segment decrease of 11% to $2.08B, Pharma Solutions segment decrease of 3% to $945M, EMEA segment decrease of 9% to $3.83B, North America segment decrease of 10% to $3.48B. |
Employees: | 21,500 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $31,234M as of Dec 31, 2023 |
Annual revenue (TTM): | $11,479M as of Dec 31, 2023 |
EBITDA (TTM): | $2,144M as of Dec 31, 2023 |
Net annual income (TTM): | -$2,565M as of Dec 31, 2023 |
Free cash flow (TTM): | $110.00M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $9,368M as of Dec 31, 2023 |
Shares outstanding: | 255,318,961 as of Mar 6, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |